microRNA information: hsa-miR-654-3p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-654-3p | miRbase |
| Accession: | MIMAT0004814 | miRbase |
| Precursor name: | hsa-mir-654 | miRbase |
| Precursor accession: | MI0003676 | miRbase |
| Symbol: | MIR654 | HGNC |
| RefSeq ID: | NR_030390 | GenBank |
| Sequence: | UAUGUCUGCUGACCAUCACCUU |
Reported expression in cancers: hsa-miR-654-3p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|
Reported cancer pathway affected by hsa-miR-654-3p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-654-3p | prostate cancer | Apoptosis pathway | "MicroRNAs miR 154 miR 299 5p miR 376a miR 376c miR ......" | 24166498 |
Reported cancer prognosis affected by hsa-miR-654-3p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-654-3p | breast cancer | progression | "MiR 654 5p attenuates breast cancer progression by ......" | 27186421 | |
| hsa-miR-654-3p | lung squamous cell cancer | progression | "We found that miR-34b and miR-520h might play impo ......" | 25702651 |
Reported gene related to hsa-miR-654-3p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-654-3p | breast cancer | EPSTI1 | "MiR 654 5p attenuates breast cancer progression by ......" | 27186421 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-654-3p | CELSR3 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; PRAD; SARC | MirTarget; PITA; miRNATAP | TCGA BLCA -0.144; TCGA BRCA -0.168; TCGA CESC -0.13; TCGA ESCA -0.53; TCGA HNSC -0.231; TCGA KIRP -0.221; TCGA LGG -0.087; TCGA LIHC -0.246; TCGA PRAD -0.305; TCGA SARC -0.121 |
hsa-miR-654-3p | SNAPIN | 12 cancers: BLCA; BRCA; COAD; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; UCEC | MirTarget | TCGA BLCA -0.052; TCGA BRCA -0.064; TCGA COAD -0.078; TCGA LGG -0.054; TCGA LIHC -0.063; TCGA LUAD -0.053; TCGA LUSC -0.061; TCGA OV -0.096; TCGA PAAD -0.079; TCGA PRAD -0.062; TCGA SARC -0.067; TCGA UCEC -0.06 |
hsa-miR-654-3p | CLEC2D | 10 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PRAD | PITA | TCGA BLCA -0.068; TCGA BRCA -0.067; TCGA HNSC -0.095; TCGA KIRC -0.108; TCGA KIRP -0.075; TCGA LGG -0.098; TCGA LUAD -0.058; TCGA LUSC -0.08; TCGA OV -0.088; TCGA PRAD -0.078 |
hsa-miR-654-3p | RCOR3 | 10 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LGG; LUAD; SARC; THCA; STAD | PITA | TCGA BLCA -0.075; TCGA BRCA -0.056; TCGA COAD -0.095; TCGA KIRC -0.058; TCGA KIRP -0.055; TCGA LGG -0.055; TCGA LUAD -0.078; TCGA SARC -0.06; TCGA THCA -0.054; TCGA STAD -0.154 |
hsa-miR-654-3p | LRP5L | 11 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LUAD; OV; PAAD; PRAD; THCA; STAD | PITA | TCGA BLCA -0.077; TCGA BRCA -0.082; TCGA HNSC -0.098; TCGA KIRC -0.11; TCGA KIRP -0.161; TCGA LUAD -0.077; TCGA OV -0.088; TCGA PAAD -0.161; TCGA PRAD -0.158; TCGA THCA -0.055; TCGA STAD -0.218 |
hsa-miR-654-3p | CHRNA10 | 9 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LUAD; LUSC; PRAD; STAD | miRNATAP | TCGA BLCA -0.091; TCGA BRCA -0.091; TCGA CESC -0.119; TCGA ESCA -0.224; TCGA KIRC -0.085; TCGA LUAD -0.079; TCGA LUSC -0.076; TCGA PRAD -0.147; TCGA STAD -0.127 |
hsa-miR-654-3p | WDSUB1 | 10 cancers: BRCA; COAD; ESCA; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD | MirTarget | TCGA BRCA -0.078; TCGA COAD -0.159; TCGA ESCA -0.091; TCGA LUAD -0.079; TCGA LUSC -0.102; TCGA OV -0.064; TCGA PRAD -0.085; TCGA SARC -0.052; TCGA THCA -0.056; TCGA STAD -0.11 |
hsa-miR-654-3p | MYBL1 | 9 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUSC; SARC; STAD | PITA | TCGA BRCA -0.236; TCGA COAD -0.206; TCGA HNSC -0.068; TCGA KIRC -0.161; TCGA KIRP -0.19; TCGA LIHC -0.061; TCGA LUSC -0.072; TCGA SARC -0.208; TCGA STAD -0.183 |
hsa-miR-654-3p | CCDC84 | 13 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BRCA -0.064; TCGA ESCA -0.096; TCGA HNSC -0.104; TCGA KIRC -0.12; TCGA KIRP -0.253; TCGA LGG -0.127; TCGA LUAD -0.129; TCGA LUSC -0.055; TCGA PAAD -0.165; TCGA PRAD -0.167; TCGA SARC -0.054; TCGA THCA -0.062; TCGA STAD -0.181 |
hsa-miR-654-3p | TRAF4 | 9 cancers: BRCA; CESC; HNSC; KIRP; LGG; LUAD; PAAD; PRAD; UCEC | miRNATAP | TCGA BRCA -0.151; TCGA CESC -0.1; TCGA HNSC -0.088; TCGA KIRP -0.07; TCGA LGG -0.072; TCGA LUAD -0.064; TCGA PAAD -0.196; TCGA PRAD -0.216; TCGA UCEC -0.082 |
Enriched cancer pathways of putative targets